Advanced Glycation End Products Promote Heart Failure Through Inducing the Immune Maturation of Dendritic Cells

2014 ◽  
Vol 172 (8) ◽  
pp. 4062-4077 ◽  
Author(s):  
Weiwei Cao ◽  
Jianwen Chen ◽  
Yanfang Chen ◽  
Xi Chen ◽  
Peiqing Liu
Keyword(s):  
Heart Failure ◽  
Dendritic Cells ◽  
Advanced Glycation End Products ◽  
Advanced Glycation ◽  
Glycation End Products ◽  
End Products ◽  
Immune Maturation

scholarly journals Association study of polymorphisms in the receptor for advanced glycation end-products (RAGE) gene with susceptibility and prognosis of heart failure

Gene ◽  
2012 ◽  
Vol 510 (1) ◽  
pp. 7-13 ◽  
Author(s):  
Carolina Rodrigues Cohen ◽  
Vanessa Backes Nascimento Diel ◽  
Vanessa Laubert La Porta ◽  
Luís Eduardo Rohde ◽  
Andréia Biolo ◽  
...  
Keyword(s):  
Heart Failure ◽  
Association Study ◽  
Advanced Glycation End Products ◽  
Advanced Glycation ◽  
Glycation End Products ◽  
End Products

scholarly journals Chronic exercise training prevents coronary artery stiffening in aortic-banded miniswine: role of perivascular adipose-derived advanced glycation end products

2019 ◽  
Vol 127 (3) ◽  
pp. 816-827 ◽  
Author(s):  
An Ouyang ◽  
T. Dylan Olver ◽  
Craig A. Emter ◽  
Bradley S. Fleenor
Keyword(s):  
Heart Failure ◽  
Coronary Artery ◽  
Exercise Training ◽  
Arterial Stiffness ◽  
Advanced Glycation End Products ◽  
Advanced Glycation ◽  
Interval Exercise ◽  
Glycation End Products ◽  
End Products ◽  
Artery Stiffness

Heart failure (HF) is associated with increased large conduit artery stiffness and afterload resulting in stiffening of the coronary arteries. Perivascular adipose tissue (PVAT) and advanced glycation end products (AGE) both promote arterial stiffness, yet the mechanisms by which coronary PVAT promotes arterial stiffness and the efficacy of exercise to prevent coronary stiffness are unknown. We hypothesized that both chronic continuous and interval exercise training would prevent coronary PVAT-mediated AGE secretion and arterial stiffness. Yucatan miniature swine were divided into four groups: control-sedentary (CON), aortic banded sedentary-heart failure (HF), aortic banded HF-continuous exercise trained (HF+CONT), and aortic banded HF-interval exercise trained (HF+IT). The left circumflex and right coronary arteries underwent ex vivo mechanical testing, and arterial AGE, elastin, and collagen were assessed. Coronary elastin elastic modulus (EEM) and elastin protein were lower and AGE was increased with HF compared with CON, which was prevented by both HF+CONT and HF+IT. Mouse aortic segments treated with swine coronary PVAT conditioned medium had lower EEM and elastin content and greater AGE secretion and arterial AGE accumulation in HF compared with CON, which was prevented by both HF+CONT and HF+IT. Aminoguanidine (AMG), an AGE inhibitor, prevented the reduction in EEM, arterial elastin content, and AGE accumulation in mouse aortic segments treated with PVAT conditioned medium in the HF group. Our data demonstrate efficacy for chronic continuous and interval exercise to prevent coronary artery stiffness via inhibition of PVAT-derived AGE secretion in a preclinical miniswine model of pressure overload-induced HF. NEW & NOTEWORTHY Our findings show that chronic continuous and interval exercise training regimens prevent coronary artery stiffness associated with inhibition of perivascular adipose tissue-derived advanced glycation end products in a translational pressure overload-induced heart failure model potentially providing an effective therapeutic option for heart failure patients.

Relation of Soluble Receptor for Advanced Glycation End Products to Predict Mortality in Patients With Chronic Heart Failure Independently of Seattle Heart Failure Score

2011 ◽  
Vol 107 (6) ◽  
pp. 938-944 ◽  
Author(s):  
Sergio Raposeiras-Roubín ◽  
Bruno K. Rodiño-Janeiro ◽  
Lilian Grigorian-Shamagian ◽  
María Moure-González ◽  
Ana Seoane-Blanco ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Advanced Glycation End Products ◽  
Soluble Receptor ◽  
Advanced Glycation ◽  
Glycation End Products ◽  
End Products

Advanced Glycation End Products Modulate the Maturation and Function of Peripheral Blood Dendritic Cells

Diabetes ◽  
2004 ◽  
Vol 53 (6) ◽  
pp. 1452-1458 ◽  
Author(s):  
C. L. Price ◽  
P. S. Sharp ◽  
M. E. North ◽  
S. J. Rainbow ◽  
S. C. Knight
Keyword(s):  
Dendritic Cells ◽  
Advanced Glycation End Products ◽  
Peripheral Blood ◽  
Advanced Glycation ◽  
Glycation End Products ◽  
End Products ◽  
And Function

scholarly journals Clinical and prognostic value of advanced glycation end-products in chronic heart failure

2007 ◽  
Vol 28 (23) ◽  
pp. 2879-2885 ◽  
Author(s):  
J. W.L. Hartog ◽  
A. A. Voors ◽  
C. G. Schalkwijk ◽  
J. Scheijen ◽  
T. D.J. Smilde ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Advanced Glycation End Products ◽  
Prognostic Value ◽  
Advanced Glycation ◽  
Glycation End Products ◽  
End Products

scholarly journals Soluble Receptor for Advanced Glycation End Products (RAGE) is a Prognostic Factor for Heart Failure

2008 ◽  
Vol 14 (2) ◽  
pp. 133-139 ◽  
Author(s):  
Yo Koyama ◽  
Yasuchika Takeishi ◽  
Takeshi Niizeki ◽  
Satoshi Suzuki ◽  
Tatsuro Kitahara ◽  
...  
Keyword(s):  
Heart Failure ◽  
Prognostic Factor ◽  
Advanced Glycation End Products ◽  
Soluble Receptor ◽  
Advanced Glycation ◽  
Glycation End Products ◽  
End Products

scholarly journals Advanced Glycation End Products Inhibit Both Infection and TransmissionIn Transof HIV-1 from Monocyte-Derived Dendritic Cells to Autologous T Cells

2011 ◽  
Vol 186 (10) ◽  
pp. 5687-5695 ◽  
Author(s):  
Nadine Nasreddine ◽  
Chloé Borde ◽  
Joël Gozlan ◽  
Laurent Bélec ◽  
Vincent Maréchal ◽  
...  
Keyword(s):  
T Cells ◽  
Dendritic Cells ◽  
Advanced Glycation End Products ◽  
Advanced Glycation ◽  
Glycation End Products ◽  
End Products ◽  
Hiv 1
Sign in / Sign up

Export Citation Format

Share Document